TMALIN

Live / Registered — Registered (as of 05 Sept 2023)

What this means for you

Registered since 05 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97363650
Registration number
7159102
Mark type
Stylized text
Filed
14 Apr 2022
Published for opposition
07 Mar 2023
Registered
05 Sept 2023
Attorney of record
Timothy T. Wang

Goods and services

  • Class 005 — Pharmaceuticals: Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Cytostatics for pharmaceutical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of antibody-drug conjugate that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Tumor suppressing agents

Owner

Prosecution history

  • 05 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 05 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
  • 04 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 03 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 03 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
  • 18 Jul 2023 — USE AMENDMENT FILED
  • 03 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 18 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
  • 02 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 07 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 07 Mar 2023 — PUBLISHED FOR OPPOSITION
  • 15 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 01 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 01 Feb 2023 — ASSIGNED TO EXAMINER
  • 20 Apr 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Marksy